Clinical Trials
13 trialsNCT03811002 2026-05-01
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06518057 2025-12-11
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
University of Washington
Phase 2 Recruiting
NCT06910761 2025-12-08
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
City of Hope Medical Center
Phase 2 Recruiting
NCT04003246 2025-03-21
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT04776083 2024-09-19
Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients
Menoufia University
Phase 3 Completed
NCT05994339 2023-08-29
Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer
Laibin People's Hospital
Phase 2/3 Unknown
NCT02768558 2021-06-02
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
RTOG Foundation, Inc.
Phase 3 Terminated
NCT04613284 2020-11-03
RELIEF
Shanghai Chest Hospital
Phase 4 Unknown
NCT02221739 2020-05-11
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
NYU Langone Health
Phase 1/2 Completed
NCT01654068 2019-04-19
Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine
University of Kentucky
Phase NA Terminated
NCT00520702 2018-10-05
3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01134146 2017-07-21
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01266512 2014-07-16
C-CRISP
Sanofi
Phase 2 Completed